Series A - IMU Biosciences

Series A - IMU Biosciences

Investment Firm

Overview

IMU is a discovery engine mapping the immune system to advance precision medicine.

Announced Date

Jan 24, 2024

Closed on Date

Jan 24, 2024

Funding Type

Series A

Highlights

Location

Europe

Social

Investor Lead

Molten Ventures

Molten Ventures

Molten Ventures is a early_stage_venture and late_stage_venture and seed and venture firm.

Participant Investors

2

Investor Name
Participant InvestorLife Extension Ventures
Participant InvestorMolten Ventures

Round Details and Background

IMU Biosciences raised $14625666 on 2024-01-24 in Series A

IMU is a discovery engine mapping the immune system to advance precision medicine.

Company Funding History

2

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Jan 01, 2023
Venture Round - IMU Biosciences
1-undefined
Jan 24, 2024
Series A - IMU Biosciences
2-14.6M

Recent Activity

There is no recent news or activity for this profile.